Ammonemia in bipolar patients on maintenance treatment with valproic acid

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 148-150

  Bocchetta, Alberto ^a   Siddu, Andrea ^a   Sardu, Claudia ^a   Sarnicola, Alessandra ^b   Martinelli, Valentina ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

AMMONIA BLOOD LEVEL; BIPOLAR DISORDER; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; HUMAN; HYPERAMMONEMIA; LABORATORY TEST; LETTER; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL;

ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; HYPERAMMONEMIA; MALE; MOOD DISORDERS; NEUROTOXICITY SYNDROMES; VALPROIC ACID;

EID: 84855382973     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318240a4a7     Document Type: Letter

References (15)

1. Harris M, Chandran S, Chakraborty N, et al. Mood-stabilizers: the archeology of the concept. Bipolar Disord. 2003;5:446-452. (Pubitemid 38072248)
2. BALANCE investigators and collaborators, Geddes JR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010;375:385-395.
3. Coulter DL, Allen RJ. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet. 1980;8181:1310-1311. (Pubitemid 10118254)
4. Altunbazak S, Baytok V, Tasouji M, et al. Asymptomatic hyperammonemia in children treated with valproic acid. J Child Neurol. 1997;12:461-463. (Pubitemid 28023537)
5. Segura-Bruna N, Rodriguez-Campello A, Puente V, et al. Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand. 2006;114:1-7. (Pubitemid 43873517)
6. Gomceli YB, Kutlu G, Cavdar L, et al. Different clinical manifestations of hyperammonemic encephalopathy. Epilepsy Behav. 2007;10:583-587. (Pubitemid 46768021)
7. Carr RB, Shrewsbury K. Hyperammonemia due to valproic acid in the psychiatric setting. Am J Psychiatry. 2007;164:1020-1027. (Pubitemid 47121390)
8. Dealberto MJ. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol. 2007;22:330-337.
9. Chicharro AV, de Marinis AJ, Kanner AM. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist? Epilepsy Behav. 2007;11:361-366. (Pubitemid 350048480)
10. Raja M, Azzoni A. Valproate-induced hyperammonaemia. J Clin Psychopharmacol. 2002;22:631-633.
11. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis. 1977;22:541-550. (Pubitemid 8116254)
12. Van Anken HC, Schiphorst ME. A kinetic determination of ammonia in plasma. Clin Chim Acta. 1974;56:151-157.
13. Stewart JT. A case of hyperammonemic encephalopathy after 11 years of valproate therapy. J Clin Psychopharmacol. 2008;28:361-362.
14. Camilleri C, Albertson T, Offerman S. Fatal cerebral edema after moderate valproic acid overdose. Ann Emerg Med. 2005;45:337-338. (Pubitemid 40261170)
15. Licari E, Calzavacca P, Warrillow SJ, et al. Life-threatening sodium valproate overdose: a comparison of two approaches to treatment. Crit Care Med. 2009;37: 3161-3164.